HCA Healthcare, Inc. — Form 8-K
Filed October 27, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 38/100
What the filing says
HCA Healthcare reported Q3 2026 revenues of $19.849 billion (up 3.6% YoY) and net income of $1.579 billion (down 3.9% YoY), with diluted EPS of $7.27 (up 4.5% YoY). The company experienced a $400 million unfavorable impact in Q3 from payer mix shift driven by uninsured volume increases due to health insurance exchange coverage losses. Nine-month revenues totaled $59.188 billion (up 5.5%); the company repurchased 7.230 million shares for $2.970 billion in Q3 and raised full-year 2026 guidance to the upper half of prior ranges. As of September 30, 2026, HCA operated 189 hospitals and ~2,600 ambulatory sites with total debt of $50.493 billion and stockholders' deficit of $8.077 billion.
Why this rating
Modest top-line growth offset by significant payer mix pressure ($400M headwind). Relative to $63.3B market cap, event is material but not trajectory-altering; guidance raise partially mitigates concerns but underlying profitability pressure evident.
See more from October 27, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.